Latest News

Frasers Group, controlled by Mike Ashley, has acquired a substantial stake in Puma, listed as XTRA:PUM. The purchase makes Frasers Group the second largest shareholder in the German sportswear company. This change in the shareholder base adds a new, high profile investor with a track record in retail and sports brands. Puma, traded as XTRA:PUM, is a global sportswear and footwear company that competes with major athletic brands for performance and lifestyle consumers. The sector continues...

If you are wondering whether Casella Waste Systems at around US$94.03 is a fair deal or a stretch, you are not alone. This article focuses squarely on what the current price might imply about value. The stock has moved 0.9% over the past week, while showing a 10.1% decline over 30 days, a 4.7% decline year to date, a 16.4% decline over 1 year, but gains of 24.7% over 3 years and 45.3% over 5 years. Recent price moves sit against a backdrop where investors are watching the waste and recycling...

Federal Signal (NYSE:FSS) reported record quarterly and full year results, with net sales and adjusted EPS at the highest levels in the company’s history. The company announced a meaningful dividend increase alongside these results. Federal Signal also appointed two experienced executives to its board of directors. Federal Signal, listed on the NYSE under ticker FSS, focuses on safety and environmental solutions, including equipment and systems used by municipal, industrial, and commercial...

CorMedix Inc. has reported past fourth-quarter 2025 revenue of US$128.62 million and net income of US$14.02 million, capping a year in which full-year revenue reached US$311.71 million and net income swung to US$163.06 million from a prior loss. The company’s reiteration of 2026 net revenue guidance of US$300 million to US$320 million, alongside advancing late-stage trials for REZZAYO and other pipeline assets, highlights management’s focus on consolidating recent product gains while...

Elekta (OM:EKTA B) drew fresh attention after its latest earnings update, where lower sales and net income figures sat alongside a strong book to bill ratio, solid China growth and ongoing cost saving efforts. See our latest analysis for Elekta. The latest earnings release appears to have reset expectations, with Elekta’s 1 day share price return of 9.64% lifting the share price to SEK62.0 and adding to a 30 day share price return of 11.91%. However, the 5 year total shareholder return of...

In recent updates, ATOSS Software AG, a German workforce management specialist, reported continued strong performance underpinned by its recurring software fees and cloud subscription model, reinforcing its profile as a profitable, high-margin SaaS provider. An interesting angle for investors is ATOSS’s exposure to complex European labor markets, where stringent workforce regulations can underpin demand for its scheduling and compliance tools while offering diversification outside more...

Dream Finders Homes (DFH) has drawn investor attention after recent trading left the stock at US$16.40, with declines over the past week, month, and past 3 months raising questions about what is priced in. See our latest analysis for Dream Finders Homes. At US$16.40, the recent 1 day, 7 day and 30 day share price returns of 4.93%, 9.24% and 16.20% respectively point to fading near term momentum. The 1 year total shareholder return of 35.36% contrasts with a 3 year total shareholder return of...

Palladyne AI (PDYN) is back in focus after reporting Q4 and full year 2025 results, along with a fresh look at its 2026 outlook that combines earnings, guidance and backlog updates in one announcement. See our latest analysis for Palladyne AI. The latest earnings and guidance update landed after a sharp run in the shares, with a 7 day share price return of 21.34% and a 90 day share price return of 55.94% that point to building momentum despite a 14.36% pullback in the last session. The 3 year...

In early March 2026, Renasant reported fourth-quarter 2025 results that beat analyst expectations, approved a US$0.23 per share quarterly dividend for payment on March 31, 2026, and disclosed an insider sale of 1,350 shares by EVP and Chief Accounting Officer Kelly Hutcheson. At the same time, investors grew more cautious about regional banks’ exposure to opaque private credit after a peer’s large loan write-off raised questions about hidden balance sheet risks across the sector. Against...

Raffles Medical Group (SGX:BSL) is back in focus after reporting full year 2025 results and proposing a final ordinary dividend of 3.0 Singapore cents per share, subject to shareholder approval in April 2026. See our latest analysis for Raffles Medical Group. The earnings and dividend announcement comes after a mixed share price run, with a 1 month share price return of 3.5% and a 3 month share price return of 4.6%. However, the 3 year total shareholder return shows a 17.2% decline,...

In February 2026, RLJ Lodging Trust reported fourth quarter 2025 revenue of US$328.59 million and net income of US$0.43 million, alongside full-year 2025 revenue of US$1.35 billion and net income of US$28.51 million, both lower than the prior year. Despite completing a relatively small US$4.3 million share repurchase program covering 586,417 shares, the more striking development was the sharp fall in full-year earnings per share from continuing operations to US$0.01, highlighting pressure on...

WillScot Holdings (WSC) recently made its fencing and perimeter security offering available nationwide, giving the company another way to support construction, event, and high risk sites alongside its modular and storage solutions. See our latest analysis for WillScot Holdings. Despite the fencing rollout, recent trading has been weak, with a 7 day share price return of 10.87% and a 30 day share price return of 13.48%. This has fed into a 1 year total shareholder return decline of 30.54%,...

Napco Security Technologies recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando, highlighting its electronic security solutions business and long-term roadmap. The company’s focus on high-margin recurring revenue and ongoing analyst interest in its operating performance has put its evolving business model under a brighter spotlight. Next, we’ll examine how this renewed analyst confidence around recurring revenue growth could influence Napco...

In early March 2026, Sumitomo Pharma secured conditional Japanese approval for AMCHePRY, the world’s first iPS cell-derived regenerative therapy for Parkinson’s disease patients whose symptoms are not adequately controlled by existing drugs, while also raising its full-year revenue and profit guidance, helped by stronger GEMTESA sales in North America and a weaker yen. The company’s decision on the same day to prepare a shelf registration for potential new share issuance, alongside its...

Capricorn Metals has reported past half-year results to 31 December 2025 showing revenue of A$327.48 million and net income of A$124.7 million, alongside guidance that it is on track for the upper end of its FY26 gold production range of 115,000–125,000 ounces at an AISC of A$1,530–A$1,630 per ounce. The company also declared its first fully franked ordinary dividend of A$0.05 per share for the half-year, signalling a shift toward direct cash returns to shareholders while continuing to use...

Positive Phase 3 data for PADCEV plus Keytruda in muscle invasive bladder cancer has put Astellas Pharma (TSE:4503) in focus, as investors weigh what the EV-304 results could mean for its oncology franchise. See our latest analysis for Astellas Pharma. The positive EV-304 update lands after a 19.78% 90 day share price return and a 12.86% year to date share price return, alongside a 73.33% 1 year total shareholder return that points to strong ongoing momentum. If this oncology news has you...

C3.ai (NYSE:AI) is under legal scrutiny after shareholders filed lawsuits alleging securities law violations and breaches of fiduciary duty. The actions follow disappointing financial results, a challenging CEO transition, and claims that material adverse information about sales and growth prospects was not properly disclosed. Regulatory and legal investigations are ongoing, raising questions about the company’s governance and leadership oversight. C3.ai, trading at $9.19, is in the...

AI restructure, e2open integration and earnings set the tone WiseTech Global (ASX:WTC) has been in focus after its half year 2026 results, an AI led restructure involving up to 2,000 job cuts, and earlier than planned cost synergies from the e2open acquisition. On the same day, the company also reported a fully franked interim dividend, reaffirmed its fiscal 2026 revenue guidance in the US$1.39b to US$1.44b range, and outlined how these moves fit into a broader shift toward an AI led...

Dynatrace executive Stephen McMahon recently purchased a significant amount of NYSE:DT stock, according to a regulatory filing. The purchase comes shortly after the company highlighted its focus on artificial intelligence at a major technology conference. The move is being watched by investors as a potential signal of internal confidence at a current share price of $39.28. For investors tracking NYSE:DT, this insider buying lands at a time when the stock has seen mixed recent performance...

Nutex Health (NUTX) is back in focus after reporting full year 2025 results and unveiling a fresh share repurchase program, pairing weaker Q4 numbers with a new commitment to buying back stock. See our latest analysis for Nutex Health. The Q4 earnings miss and new buyback plan landed against a sharp reset in sentiment. A 90 day share price return of 50.14% decline and year to date share price return of 39.08% decline contrast with a 1 year total shareholder return of 102.15%, suggesting...

If you are wondering whether Lithia Motors' current share price reflects its true worth, you are not alone. This article is designed to help you unpack that question clearly. The stock last closed at US$259.65, with recent returns of a 7.1% decline over 7 days, a 24.6% decline over 30 days, a 21.9% decline year to date, and a 14.2% decline over 1 year, while the 3 year return is 7.9% and the 5 year return is a 32.2% decline. Recent share price moves have put more attention on how the market...

Spin Master (TSX:TOY) has recorded major non cash impairment charges tied largely to its Melissa & Doug brand, contributing to a sizeable net loss. The company is contending with a weak U.S. toy market and tariffs, which have weighed on recent results. Management is putting more focus on digital games and new toy launches, including an expansion of its award winning Primal Hatch brand. Spin Master enters this period with its share price at CA$18.47 and a 1 year return of 29.1% decline,...

A Brazilian court halted Equinox Gold's transfer of mineral rights tied to a $1b sale of gold mines to China's CMOC Group. The decision follows a legal challenge from a state run firm that claims a contract breach in the transaction. The ruling directly affects a major asset sale and adds legal uncertainty around Equinox Gold's Brazilian operations. For you as an investor following TSX:EQX, this court action lands in the middle of the company's role as a mid tier gold producer with assets...

Nexi S.p.A. has announced an annual dividend of €0.3000 per share payable on May 20, 2026, following full-year 2025 results that showed sales of €6,273 million and a net loss of €3,377 million versus a net profit a year earlier. At the same time, Nexi is deepening its work with Google Cloud and open commerce standards to support AI-driven “agentic commerce,” aiming to pair advanced payments infrastructure with emerging shopping and fraud-detection technologies. We’ll now examine how Nexi’s...